secwatch / observer
8-K filed May 17, 2024, 7:59 PM ET ticker VERA CIK 0001831828
other confidence high sentiment neutral materiality 0.10

Vera Therapeutics stockholders re-elect two Class III directors; ratify KPMG as auditor

Vera Therapeutics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Vera Therapeutics, Inc. shareholders approved Ratification of the Selection of KPMG LLP as the independent registered public accounting firm at the 2024-05-15 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2024-05-15
Exact text from the filing
Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Vera Therapeutics, Inc. shareholders approved Election of Directors at the 2024-05-15 meeting.

Proposal
director election
Outcome
passed
Meeting
2024-05-15
Exact text from the filing
Proposal 1. Election of Directors The Company’s stockholders elected the three persons listed below as Class III Directors, each to serve until the Company’s 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or, if sooner, such director’s death, resignation or removal.
View on SEC.gov

211 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Vera Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-24-061872
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.